# A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia

> **NCT02811991** · PHASE2,PHASE3 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 348 (actual)

## Conditions studied

- Post-operative Analgesia

## Interventions

- **DRUG:** Paracetamol injection
- **DRUG:** Normal Saline injection
- **DRUG:** Morhpine PCA

## Key facts

- **NCT ID:** NCT02811991
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-09-14
- **Final completion:** 2019-05
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02811991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02811991, "A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02811991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*